Neurológia pre prax 4/2023
Improved cognitive function and employment in patients with relapsing multiple sclerosis treated with ocrelizumab
Cognitive impairment has a significant impact on the quality of life of MS patients. It leads to impairment in social activities, physical independence, ability to manage daily activities, ability to take regular medication and employment. The aim of modern treatment should not only be to achieve stabilisation of the disease, but also to improve cognitive function and therefore employment. This article presents recent information on the positive effect of ocrelizumab treatment on these parameters.
Keywords: multiple sclerosis, ocrelizumab, cognitive function, employment
